真核延长因子eEF1A功能研究进展

程君; 芮耀诚

doi:10.3969/j.issn.1006-0111.2012.02.003

真核延长因子eEF1A功能研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.003

程君,
芮耀诚

第二军医大学药学院药理学教研室, 上海 200433

Advance in function of the eukaryotic elongation factor eEF1A

Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

摘要: 真核延长因子(eEFs)是一类在蛋白质合成过程中发挥肽链延伸作用的重要分子,在真核生物体内它有eEF1和eEF2两个亚型。其中在肽链延伸过程中起主要作用的eEF1A 是eEF1的一个亚型,它不但能促进氨酰基-tRNA(aa-tRNA)与核糖体的A位点结合,发挥肽链延伸功能;而且近年来大量的研究表明它在细胞凋亡、肿瘤的发生、细胞内信号转导及心血管系统的调节方面均发挥了重要作用,而且这些作用与它在蛋白合成中的功能无关;这表明eEF1A是一个多功能蛋白,能够成为一个潜在的疾病防治的靶点。本文就国内外近几年来有关eEF1A的研究做一综述,介绍真核延长因子eEF1A功能研究的进展。
- 真核延长因子eEF1A /
- 蛋白合成 /
- 细胞凋亡 /
- 肿瘤 /
- 心血管系统
Abstract: Eukaryotic elongation factors(eEFs)was a kind of important molecules that assist in elongating the polypeptide chain in the protein biosynthesis of the organisms. It had two subtypes in eukaryotic organism:eEF1 and eEF2. One subtype of eEF1:eEF1A played the main functions in elongating the peptide chain, which carried the aminoacyl-tRNA (aa-tRNA)on the A site of the ribosome,and many studies indicated that eEF1A played another roles range from cell apoptosis,tumorigenesis,signal transduction to the regulation of the cardiovascular system, and these functions were not related to the protein synthesis. All of this demonstrated eEF1A was a multifunction protein,which could be a potential target of the disease prevention and cure. The advance in function of the eukaryotic elongation factor eEF1A in recently years were introduced in this article.
- eukaryotic elongation factor eEF1A /
- protein biosynthesis /
- cell apoptosis /
- tumor /
- cardiovascular system

[1]	Lamberti A,araglia M,longo O,et al.The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis[J]. Amino Acids,2004,26(4):443.
[2]	Infante C,sensio E,aavate JP,et al. Molecular characterization and expression analysis of five different elongation factor 1 alpha genes in the flatfish Senegalese sole (Solea senegalensis Kaup): Differential gene expression and thyroid hormones dependence during metamorphosis[J]. BMC Mol Biol,2008,9:19.
[3]	Maria K,Mateyak,Kinzy TG. eEF1A: Thinking outside the ribosome[J]. J Biol Chem,2010,5(4):432.
[4]	Ejiri Shin ichiro. Moonlighting functions of polypeptide elongation factor 1:from actin bundling to zinc finger protein r1-associated nuclear localization[J]. Biotechnol Biochem,2002,66(1):1.
[5]	Khalyfa A,Bourbeau D,Chen E,et al. Characterization of Elongation Factor-1A (eEF1A-1) and eEF1A-2/S1 Protein Expression in Normal and wasted Mice[J]. J Biol Chem,2001,276(25):22915.
[6]	Newbery HJ,Loh DH,Donoghue JE,et al. Translation elongation factor eEF1A2 is essential for post-weaning survival in mice[J]. J Biol Chem,2007,282(39):28951.
[7]	Pan J,Ruest LB,Xu SY,et al. Immuno-characterization of the switch of peptide elongation factors eEF1A-1/EF-1a and eEF1A-2/S1 in the central nervous system during mouse development[J]. Dev Brain Res,2004,149:1.
[8]	Andersen GR,Nissen P,Nyborg J. Elongation factors in protein biosynthesis[J]. Trends Biochem Sci,2003,28(8):434.
[9]	Villa E,Sengupta J,Trabuco LG,et al. Ribosome-induced changes in elongation factor Tu conformation control GTP hydrolysis[J]. Proc Natl Acad Sci,2009,106(4):1063.
[10]	Ruest LB,Marcotte R,Wang E. Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase3-mediated apoptosis[J]. J Biol Chem,2002,277(7):5418.
[11]	Borradaile NM, Buhman KK, Listenberger LL, et al. A critical role for eukaryotic elongation factor 1A1 in lipotoxic cell death[J]. Mol Biol Cell,2006,17:770.
[12]	Talapatra1 S,Wagner J,Thompson CB. Elongation factor-1 alpha is a selective regulator of growth factor withdrawal and ER stress-induced apoptosis[J]. Cell Death and Differ, 2002,9:856.
[13]	Li HT,Su YP,Cheng TM,et al. The interaction between interferon-induced protein with tetratricopeptide repeats-1 and eukaryotic elongation factor-1A[J]. Mol Cell Biochem,2010, 337:101.
[14]	Mansillaa F,Hansenb LL,Jakobsena H,et al. Deconstructing PTI-1: PT1-1 is a truncated, but not mutated form of translation elongation factor 1A1, eEF1A1[J]. Biochim Biophys Acta,2005,1727(2):116.
[15]	Zhang JP,Guo HT,Mi ZY,et al. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells[J]. Exp Cell Res,2009,315:304.
[16]	Anand N,Urthy S,Mann G,et al.Protein elongation factor eEF1A2 is a putative oncogene in ovarian cancer[J]. Nat Genet,2002,31:301.
[17]	Tomlinson VA,ewbery HJ,ray NR,et al. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours[J]. BMC cancer,2005,5:113.
[18]	Morikawa E,Moskowitz M,Huang Z,et al. L-Arginine infusion promotes nitric oxide dependent vasodilation,increases regional blood flow and reduces infarct volume in the rat[J]. Stroke,1994,25(2):429.
[19]	Yan GJ,You B,Chen SP,et al. Tumor necrosis factor-a downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1A1[J]. Circ Res,2008,103(12):591.
[20]	Picchi A,Gao X,Belmadani S. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome[J]. Circ Res,2006,99:69.
[21]	Agnoletti L,Curello S,Bachetti T,et al. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic:role of tumor necrosis factor-alpha[J]. Circulation, 1999,100:1983.
[22]	Gross SR,Kinzy TG. Tranlation elongation factor 1A is essential for regulation of actin cytoskeleton and cell morphology[J]. Nat Struct Mol Boil,2005,12:772.
[23]	Leclercq TM, Moretti PAB, Vadas MA, et al.Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity[J]. J Biol Chem,2008,283:9606.
[24]	Gillardon F. Interaction of elongation factor 1-a with leucine-rich repeat kinase 2 impairs kinase activity and microtubule bundling in vitro[J]. Neuroscience,2009,163:533.
[25]	Yuka Hotokezaka,Udo Tobben,Hitoshi Hotokezaka,et al. Interaction of the Eukaryotic Elongation Factor 1A with NewlySynthesized Polypeptides[J]. J Biol Chem,2002,277(21):18545.
[26]	Shamovsky Iiya,Ivannikov Maxim,Kandel ES,et al. RNA-mediated response to heart shock in mammalian cells[J]. Nature,2006,440(23):556.

[1]	李想, 陆鸿远, 张明玉, 高欢, 姚东, 许子华. 米格列醇激活UCP1介导棕色脂肪对冷暴露小鼠损伤的研究 . 药学实践与服务, 2025, 43(1): 1-6. doi: 10.12206/j.issn.2097-2024.202404005
[2]	毛智毅, 王筱燕, 陈晓颖, 汤逸斐. 度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032
[3]	岳春华, 贲永光, 王海桥. 基于NLRP1炎症小体探讨百合知母汤抗抑郁的作用机制 . 药学实践与服务, 2024, 42(8): 325-333. doi: 10.12206/j.issn.2097-2024.202401033
[4]	白学鑫, 陈玉平, 盛春泉, 武善超. 具核梭杆菌小分子抑制剂的筛选及其抗结直肠癌活性研究 . 药学实践与服务, 2024, 42(12): 503-507. doi: 10.12206/j.issn.2097-2024.202405009
[5]	崔晓林, 付晓菲, 杜艳红, 刘娟, 朱茜, 刘子祺. 临床药师参与吉瑞替尼致QTc间期延长的病例分析 . 药学实践与服务, 2024, 42(6): 263-266. doi: 10.12206/j.issn.2097-2024.202309050
[6]	徐璐璐, 刘爱军. 丹参白术方“异病同治”冠心病、血管性痴呆、特发性膜性肾病的网络药理学作用机制研究 . 药学实践与服务, 2024, 42(12): 1-8. doi: 10.12206/j.issn.2097-2024.202312027
[7]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[8]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
[9]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[10]	段禹, 刘爱军. 活血化瘀法治疗血管性痴呆的研究进展 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202408045
[11]	修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星. 全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054
[12]	姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量. 巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
[13]	杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛. 正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027
[14]	陈怡君, 王卓, 何苗, 张宇, 田泾. 泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
[15]	刘汝雄, 杨万镇, 涂杰, 盛春泉. 铁死亡调控蛋白GPX4的小分子抑制剂研究进展 . 药学实践与服务, 2024, 42(9): 375-378. doi: 10.12206/j.issn.2097-2024.202312075
[16]	陈炳辰, 王思真, 郭贝贝, 杨峰. 紫杉醇棕榈酸酯的合成及其脂质体的制备与处方研究 . 药学实践与服务, 2024, 42(9): 379-384, 410. doi: 10.12206/j.issn.2097-2024.202404062
[17]	冯婷婷, 张景翔, 王彦, 许维恒, 张俊平. ANXA3基因及蛋白的研究进展 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202309023
[18]	冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军. 雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055

点击查看大图

计量

文章访问数: 6224
HTML全文浏览量: 614
PDF下载量: 392
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

真核延长因子eEF1A功能研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.003

Advance in function of the eukaryotic elongation factor eEF1A

计量

真核延长因子eEF1A功能研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.003

第二军医大学药学院药理学教研室, 上海 200433

English Abstract

Advance in function of the eukaryotic elongation factor eEF1A

Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

全文HTML

目录

留言板

真核延长因子eEF1A功能研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.003

Advance in function of the eukaryotic elongation factor eEF1A

计量

出版历程

真核延长因子eEF1A功能研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.003

第二军医大学药学院药理学教研室, 上海 200433

English Abstract

Advance in function of the eukaryotic elongation factor eEF1A

Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

全文HTML

目录